IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Gilead Sciences, Inc.

Q2 2026 Holdings

Filed 2026-08-03 | 5 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc.(RCUS)COM03969F109$968.8M31,424,76058.8%
Lakefront Biotherapeutics(GLPG)SPON ADR36315X101$500.2M16,707,47730.3%
Assembly Biosciences Inc.(ASMB)COM NEW045396207$136.8M4,977,0898.3%
Kyverna Therapeutics Inc.(KYTX)COM501976104$36.8M4,126,1192.2%
Xilio Therapeutics Inc.(XLO)COM98422T100$6.2M650,3890.4%